55 reports

The OraQuick HCV Rapid Antibody Test is the only CLIA-waived HCV test.

  • Antibiotic Resistance
  • Alere Inc.
  • Cepheid
  • Hologic, Inc.
  • Roche Group

Periodic Assessment of the Molecular Diagnostic Market for HCV Qualitative Tests in France, 2014 Total number of clinical diagnostic labs by segment: small, medium and large hospitals, independent (private) labs Number of clinical diagnostic molecular labs by segment: small, medium

  • Antibiotic Resistance
  • Antiviral
  • Infectious Disease
  • Molecular Diagnostics
  • France

Periodic Assessment of the Molecular Diagnostic Market for HCV Genotyping Tests in France, 2014 Total number of clinical diagnostic labs by segment: small, medium and large hospitals, independent (private) labs Number of clinical diagnostic molecular labs by segment: small, medium

  • Antibiotic Resistance
  • Infectious Disease
  • Molecular Diagnostics
  • Pathology
  • France

Periodic Assessment of the Molecular Diagnostic Market for HCV Qualitative Tests in UK, 2014 Total number of clinical diagnostic labs by segment: small, medium and large hospitals, independent (private) labs Number of clinical diagnostic molecular labs by segment: small, medium and

  • Antibiotic Resistance
  • Antiviral
  • Infectious Disease
  • Molecular Diagnostics
  • United Kingdom

Periodic Assessment of the Molecular Diagnostic Market for HCV Genotyping Tests in UK, 2014 Total number of clinical diagnostic labs by segment: small, medium and large hospitals, independent (private) labs Number of clinical diagnostic molecular labs by segment: small, medium and

  • Antibiotic Resistance
  • Infectious Disease
  • Molecular Diagnostics
  • Pathology
  • United Kingdom

Periodic Assessment of the Molecular Diagnostic Market for HCV Qualitative Tests in Italy, 2014 Total number of clinical diagnostic labs by segment: small, medium and large hospitals, independent (private) labs Number of clinical diagnostic molecular labs by segment: small, medium

  • Antibiotic Resistance
  • Antiviral
  • Infectious Disease
  • Molecular Diagnostics
  • Italy

Periodic Assessment of the Molecular Diagnostic Market for HCV Genotyping Tests in Italy, 2014 Total number of clinical diagnostic labs by segment: small, medium and large hospitals, independent (private) labs Number of clinical diagnostic molecular labs by segment: small, medium a

  • Antibiotic Resistance
  • Infectious Disease
  • Molecular Diagnostics
  • Pathology
  • Italy

Periodic Assessment of the Molecular Diagnostic Market for HCV Qualitative Tests in Germany, 2014 Total number of clinical diagnostic labs by segment: small, medium and large hospitals, independent (private) labs Number of clinical diagnostic molecular labs by segment: small, mediu

  • Antibiotic Resistance
  • Antiviral
  • Infectious Disease
  • Molecular Diagnostics
  • Germany

Periodic Assessment of the Molecular Diagnostic Market for HCV Genotyping Tests in Germany, 2014 Total number of clinical diagnostic labs by segment: small, medium and large hospitals, independent (private) labs Number of clinical diagnostic molecular labs by segment: small, medium

  • Antibiotic Resistance
  • Infectious Disease
  • Molecular Diagnostics
  • Pathology
  • Germany

Periodic Assessment of the Molecular Diagnostic Market for HCV Qualitative Tests in Spain, 2014 Total number of clinical diagnostic labs by segment: small, medium and large hospitals, independent (private) labs Number of clinical diagnostic molecular labs by segment: small, medium

  • Antibiotic Resistance
  • Antiviral
  • Infectious Disease
  • Molecular Diagnostics
  • Spain

Periodic Assessment of the Molecular Diagnostic Market for HCV Genotyping Tests in Spain, 2014 Total number of clinical diagnostic labs by segment: small, medium and large hospitals, independent (private) labs Number of clinical diagnostic molecular labs by segment: small, medium a

  • Antibiotic Resistance
  • Infectious Disease
  • Molecular Diagnostics
  • Pathology
  • Spain

THE NOVEL TEST DETECTS PLACENTAL ALPHA MICROGLOBULIN-## (PAMG-##) IN PATIENTS PRESENTING WITH SIGNS AND SYMPTOMS OF PRETERM LABOR.

  • Antibiotic Resistance
  • Infectious Disease
  • Lung Cancer
  • Tuberculosis
  • QIAGEN N.V.

HCV VIRAL LOAD TEST - PROTEASE INHIBITOR (RG##) HCV VIRAL LOAD TEST - PROTEASE INHIBITOR (RG##) PRODUCT OVERVIEW HCV VIRAL LOAD TEST - PROTEASE INHIBITOR (RG##) - PRODUCT STATUS Market Category Developed By Pipeline Territory Highest Stage

  • Antibiotic Resistance
  • Lung Cancer
  • Monoclonal Antibody
  • Targeted Therapy
  • Roche Group

The primary outcome measures of this study are to asses the adverse events, serious adverse events, laboratory results (hematology, serum blood chemistry, hepatitis tests, standard urinalysis dipstick assessment, coagulation studies)or assessment of the incidence of pneumonitis.

  • Antibiotic Resistance
  • Cancer
  • Lung Cancer
  • United States
  • Product Initiative
  • UTIS TESTING SEGMENT IS EXPECTED TO DOMINATE THE MARKET IN 2016
  • ITALY: INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)

Abbott launched RealTime HCV Genotype II test, a HCV genotyping test for patients in the U. S.

  • Antibiotic Resistance
  • Diagnostics
  • Infectious Disease
  • Lung Cancer
  • Ultrasound
  • CLINICAL PCR AND OTHER NAAT MARKET, BY TYPE OF NAAT, WORLDWIDE, 2021

Assays that are currently available include CMV, HBV, HCV, and HIV-##.

  • Antibiotic Resistance
  • Biotech Diagnostics
  • Lung Cancer
  • Molecular Diagnostics
  • Biocartis S.A.

Primary tumor site was testis in ## patients and mediastinum in ##.

  • Immunotherapy
  • Lung Cancer
  • Oncology
  • Therapy
  • Ultrasound

IN VITRO DIAGNOSTICS--> INFECTIOUS DIAGNOSTICS--> HEPATITIS TEST KITS--> HEPATITIS C TEST KITS CLASS III PMA RANDOM ACCESS SYSTEM - HCV GT ASSAY RANDOM ACCESS SYSTEM - HCV GT ASSAY PRODUCT OVERVIEW RANDOM ACCESS SYSTEM - HCV GT ASSAY - PROD

  • Antibiotic Resistance
  • Infectious Disease
  • Lung Cancer
  • Tissue Banking
  • Seegene, Inc.

PRIMARY TUMOR SITE WAS TESTIS IN ## PATIENTS AND MEDIASTINUM IN ##.

  • Antibiotic Resistance
  • Hospital
  • Lung Cancer
  • United States
  • Merck & Co., Inc.

Antiviral responses in HCV- and HBV-infected patients have been observed as measured by declines in HCV RNA and quantitative HBV surface antigen.

  • Lung Cancer
  • Therapy
  • United States
  • Product Initiative
  • Bristol-Myers Squibb Company
  • Abbott Diagnostics Pipeline Products Overview

Lung Cancer PD-##/ PDL-## COMPANION DIAGNOSTIC ASSAY - LUNG CANCER PD-##/ PDL-## COMPANION DIAGNOSTIC ASSAY - LUNG CANCER PRODUCT OVERVIEW PD-##/ PDL-## COMPANION DIAGNOSTIC ASSAY - LUNG CANCER - PRODUCT STATUS PD-##/ PDL-

  • Antibiotic Resistance
  • Leukemia
  • Lung Cancer
  • Therapy
  • United States

CEPHEID OUTSIDE US IN APPROVAL PROCESS CLASS III As of May, 2018 GENEXPERT OMNI - HIV-## VIRAL LOAD TEST GENEXPERT OMNI - HIV-## VIRAL LOAD TEST PRODUCT OVERVIEW GENEXPERT OMNI - HIV-## VIRAL LOAD TEST - PRODUCT STATUS MARKET CATEGORY DEVELOPED BY P

  • Antibiotic Resistance
  • Lung Cancer
  • Point Of Care Testing
  • United States
  • Cepheid

Primary tumor site was testis in ## patients and mediastinum in ##.

  • Cancer
  • Lung Cancer
  • Pharmaceutical
  • Therapy
  • Merck & Co., Inc.

Primary tumor site was testis in ## patients and mediastinum in ##.

  • Antibiotic Resistance
  • Lung Cancer
  • Pharmaceutical
  • Therapy
  • Ultrasound

Quidel Corp United States Early development Class II ##(k) September, 2023 SAVANNA - HCV ASSAY SAVANNA - HCV ASSAY PRODUCT OVERVIEW SAVANNA - HCV ASSAY - PRODUCT STATUS Market Category Developed By Pipeline Territory Highest Stage of Development Device Class Regulatory Pa

  • Antibiotic Resistance
  • In Vitro Diagnostic Reagent
  • Infectious Disease
  • United States
  • Quidel Corporation

Primary tumor site was testis in ## patients and mediastinum in ##.

  • Antibiotic Resistance
  • Lung Cancer
  • Ultrasound
  • United States
  • Merck & Co., Inc.

Antiviral responses in HCV- and HBV-infected patients have been observed as measured by declines in HCV RNA and quantitative HBV surface antigen.

  • Antibiotic Resistance
  • Hospital
  • Lung Cancer
  • Therapy
  • Ultrasound

BIODESIX VERISTRAT TEST IS A PREDICTIVE AND PROGNOSTIC BLOOD-BASED PROTEOMIC TEST FOR PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER.

  • Hospital
  • Lung Cancer
  • Targeted Therapy
  • Therapy
  • Bristol-Myers Squibb Company

Primary tumor site was testis in ## patients and mediastinum in ##.

  • Hospital
  • Immunotherapy
  • Lung Cancer
  • Therapy
  • Ultrasound

Median OS was ##. ## mo (median OS was not reached in the HCV and HBV cohorts) and the ##-mo OS rate was ##. ## percent.

  • Antibiotic Resistance
  • Cancer
  • Lung Cancer
  • United States
  • Eisai Co., Ltd.